Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

KaloBios Pharmaceuticals Inc (OTC Pink - Current Information:KBIO)

2.80
Real-Time Quote
As of 2:12pm ET
 0.00 / 0.00%
Today’s Change
1.95
Today|||52-Week Range
18.26
-28.21%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$41.7M

Company Description

KaloBios Pharmaceuticals, Inc. engages as a biopharmaceutical company, which focuses on the development of monoclonal antibody therapeutics. The company develops a portfolio of proprietary and patient-targeted monoclonal antibodies designed to treat severe life-threatening or debilitating diseases for which there is an unmet medical need, with a clinical focus on severe respiratory diseases and cancer. Its antibody technology, Humaneered, treats serious medical conditions with a primary clinical focus on respiratory diseases and cancer. The company was founded on March 15, 2000 and is headquartered in Brisbane, CA.

Contact Information

KaloBios Pharmaceuticals, Inc.
1000 Marina Boulevard
Brisbane California 94005-1878
P:(650) 243-3100
Investor Relations:

Employees

Shareholders

Individual stakeholders79.24%
Other institutional42.94%
Mutual fund holders0.01%

Top Executives

Cameron DurrantChairman & Chief Executive Officer
Dave TousleyChief Financial Officer
Morgan LamChief Scientific Officer
Eugene Irwin DavisChief Restructuring Officer
Edward PainterHead-Communications & Investor Relations